Literatur
Mendonca LL, Khamashta MA, Nelson-Piercy C, Hughes GRV (2000) Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology 39:880–882
Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA (1989) The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol 160:1525–1531
Vermillion ST, Scardo JA, Lashus AG, Wiles HB (1997) The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 177:256–261
Czeizel AE, Rockenbauer M (1997) Population-based case-control study of teratogenic potential of corticosteroids. Teratology 56:335–340
Park-Wyllie L, Mazzotta P, Pastuszak A et al (2000) Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 62:385–392
Committee on Drugs. American Academy of Pediatrics (2001) The transfer of drugs and other chemicals into human milk. Pediatrics 108:776–789
Østensen M (2006) Antirheumatische Therapie und Reproduktion. Z Rheumatol 65:217–224
Wolfe MS, Cordero JF (1985) Safety of chloroquine in chemosuppression of malaria during pregnancy. BMJ 290:1466–1467
Fraga A, Mintz G, Orozco J et al (1974) Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheumatol 1:293–298
Costedoat-Chalumeau N, Amoura Z, Duhaut P et al (2004) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 50:3057–3058
Motta M, Tincani A, Faden D et al (2005) Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 25:86–89
Costedoat-Chalumeau N, Amoura Z, Huong du LT et al (2005) Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 4:111–115
Janssen NM, Genta MS (2000) The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation. Arch Intern Med 160:610–619
Temprano KK, Bandlamudi R, Moore TL (2005) Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 35:112–121
O’Morain C, Smethurst P, Dore CJ et al (1984) Reversible male infertility due to sulphasalazine: studies in men and rat. Gut 25:1078–1084
Ferrero S, Ragni N (2004) Inflammatory Bowel Disease: Management issues during pregnancy. Arch Gynecol Obstet 270:79–85
Norgard B, Czeizel AE, Rockenbauer M et al (2001) Population based case control study of the safety of sulphasalazine use during pregnancy. Aliment Pharmacol Ther 15:483–486
Jarnerot G, Into-Malmberg MB (1979) Sulphasalazine treatment during breast feeding. Scand J Gastroenterol 14:869–871
Østensen M (2004) Disease specific problems related to drug therapy in pregnancy. Lupus 13:746–750
Hernandez-Diaz S, Werler MM, Walker AM et al (2001) Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 153:961–968
Bar Oz B, Hackman R, Einarson T et al (2001) Pregnancy outcome after cyclosporine therapy during pregnancy: A meta-analysis. Transplantation 71:1051–1055
Lamarque V, Leleu MF, Monka C et al (1997) Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun. Transplant Proc 29:2480
Moskovitz DN, Bodian C, Chapman ML et al (2004) The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 99:656–661
Meehan RT, Dorsey JK (1987) Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol 14:252–258
Ramsey-Goldman R, Mientus JM, Kutzer JE et al (1993) Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol 20:1152–1157
Østensen M (2004) Disease specific problems related to drug therapy in pregnancy. Lupus 13:746–750
Briggs GG (2005) Drugs in pregnancy and lactation, 7th edn. Lippincott Williams & Wilkins, Baltimore
Zerner J, Doil KL, Drewry J, Leeber DA (1981) Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med 26:99–102
Lloyd ME, Carr M, McElhatton P et al (1999) The effects of methotrexate on pregnancy, fertility and lactation. O J Med 92:551–563
Østensen M, Hartmann H, Salvesen K (2000) Low dose weekly methotrexate in early pregnancy: A case series and review of the literature. J Rheumatol 27:1872–1875
Chakravarty EF, Sanchez-Yamamoto D, Bush TM (2003) The use of disease-modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: A survey of practice patterns and pregnancy outcomes. J Rheumatol 30:241–246
Johns DG, Rutherford LD, Leighton PC et al (1972) Secretion of methotrexate into human milk. Am J Obstet Gynecol 112:978–980
Brent RL (2001) Teratogen Update: Reproductive risks of leflunomide, a pyrimidine synthesis inhibitor. Counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 63:106–112
Boumpas DT, Austin HA, Vaughan EM et al (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369
Mirkes PE (1985) Cyclophosphamide teratogenesis: A review. Teratog Carcinog Mutagen 5:75–88
Enns GM, Roeder E, Chan RT et al (1999) Apparent cyclophosphamide embryopathy: A distinct phenotype? Am J Med Genet 86:237–241
Wiernik PH, Duncan JH (1971) Cyclophosphamide in human milk. Lancet 1:912
Pergola PE, Kancharla A, Riley DJ (2001) Kidney transplantation during the first trimenon of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus and prednisone. Transplantation 71:994–997
Sifontis NM, Coscia LA, Constantinescu S et al (2006) Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82:1698–1702
Østensen M, Khamashta M, Lockshin M et al (2006) Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8:209
Strangfeld A, Listing J, Rau R et al (2007) Pregnancy outcome after exposure to biologics: Results from the German Biologics Register RABBIT. Arthritis Rheum 56 (Suppl):S 311
Katz JA, Antoni C, Keenan GF et al (2004) Outcome of pregnancy in women receiving infliximab for the treatment of crohn‘s disease and rheumatoid arthritis. Am J Gastroenterol 99:2385–2392
Orozco C, Dao K, Cush JJ et al (2005) Safety of TNF inhibitors during pregnancy in patients with inflammatory arthritis. ACR Annual Scientific Meeting San Diego, Abstr. F12
Carter JD, Ladhani A, Ricca L et al (2007) A safety assessment of TNF Antagonists during pregnancy: A review of the FDA database. Arthritis Rheum 56(Suppl):S 286
Kallinich T, Haffner D, Niehues T et al (2007) Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement. Pediatrics 119:e474–e483
Berkenstad M, Weisz B, Cuckle H et al (2005) Chromosomal abnomalities and birth defects among couples with colchicine treated familial Mediterranean fever. Am J Obstet Gynecol 193:1513–1516
Ben-Chetrit E, Levy M (2003) Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 62:916–919
Rabinovitch O, Zemer D, Kukia E et al (1992) Colchicine treatment in conception and pregnancy: 231 pregnancies in patients with familial Mediterranean fever
Ben-Chetrit E, Berkun Y, Ben-Chetrit E et al (2004) The outcome of pregnancy in the wives of men with familial Mediterranian fever. Semin Arthritis Rheum 34:549–552
Committee on Drugs, American Academy of Pediatrics (1994) The transfer of drugs and other chemicals into human milk. Pediatrics 93:137–150
Radder CM, Roelen DL, van de Meer-Prins et al (2004) The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 191:815–820
Schaefer C, Hannemann D, Keister R et al (2006) Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study. Thromb Haemost 95:949–957
Segal JB, Streiff MB, Hofmann LV et al (2007) Management of venous thromboembolism: A systematic review for a practice guideline. Ann Intern Med 146:211–222
Bates SM, Greer IA, Pabinger I et al (2008) Venous thromboembolism, thrombophilia, antithrombotic therapy and pregnancy. American college of chest physicians evidence-based clinical practice guidelines 8th edn. Chest 133:844–886
Chan WS, Anand S, Ginsberg JS (2000) Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 160:191–196
James AH, Grotegut CA, Brancazio LR et al (2007) Thromboembolism in pregnancy: Recurrence and its prevention. Semin Perinatol 31:167–175
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Krüger, K., Gromnica-Ihle, E. & im Auftrag der Kommission Pharmakotherapie der DGRh. Pharmakotherapie in der Schwangerschaft und Stillzeit. Z. Rheumatol. 68, 169–173 (2009). https://doi.org/10.1007/s00393-008-0423-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-008-0423-1